Discover how ultra-early epilepsy surgeries transform the lives of children with drug-resistant seizures, preventing long-term brain damage.
A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.
Beyond seizures: With experimental drug, Stoke aims to restore developmental loss in Dravet syndrome
Stoke Therapeutics is developing a drug designed to reduce seizures and restore some of their lost developmental function.
An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.
A large cohort study sheds new light on neurodevelopmental risk in children after prenatal antiseizure medication exposure, ...
Dravet syndrome affects about 1 in 17,500 children. Having two daughters with the condition is “extraordinarily uncommon.” ...
If you see someone having a seizure or fit, there are some simple things you can do to help.
13don MSN
EPILEPSY THAT DOES NOT RESPOND TO MEDICINES. WHEN SURGERY BECOMES THE BEST MEDICAL DECISION
Many families face the challenge of drug-resistant epilepsy, questioning the transition from medication to surgery.
Identifying childhood epilepsy at an early stage is vital; a late diagnosis can hinder a child's growth and education. Specialists stress that this often-misunderstood brain condition, which faces ...
The Epilepsy Society has welcomed a new experimental treatment for children with Dravet syndrome which researchers say is safe and can help reduce seizures dramatically.
A new drug trialled in Sheffield has dramatically reduced seizures in children with a rare and severe form of epilepsy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results